Lab21 Licenses MDx Patents from Cooperative Diagnostics | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Lab21 has licensed worldwide rights to a suite of patents from Cooperative Diagnostics covering real-time PCR technology that the firm will incorporate into molecular diagnostic kits.

The Cambridge, UK-based diagnostic products and services firm said that as part of the agreement it has exclusive use of the technology on a set of biomarker targets for the oncology and infectious disease areas. Financial and other terms of the pact were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.